financetom
Business
financetom
/
Business
/
Merck, Moderna Begin Phase 3 Trial of V940, Keytruda Combination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck, Moderna Begin Phase 3 Trial of V940, Keytruda Combination
Oct 28, 2024 10:53 PM

07:34 AM EDT, 10/28/2024 (MT Newswires) -- Merck ( MRK ) and Moderna ( MRNA ) said Monday it initiated a phase 3 trial evaluating the investigational V940 in combination with Keytruda to treat certain types of non-small cell lung cancer.

The first patients in the trial were enrolled in Canada.

Price: 104.15, Change: +0.17, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved